Authors:
MOZLEY PD
BARRACLOUGH ED
DRESEL S
STUBBS JB
FINKELMAN C
MATHUR A
SPARKS RB
PATEL M
SMITH T
THAKUR M
ALAVI A
Citation: Pd. Mozley et al., DOSIMETRY OF ANTI-SSEA-1 - A TC-99M LABELED, IGM MURINE ANTIBODY TO HUMAN GRANULOCYTES, The Journal of nuclear medicine, 39(5), 1998, pp. 1176-1176
Citation: Rb. Sparks et Ja. Siegel, COMPARISON OF POINT-SOURCE AND MONTE-CARLO METHODS IN DETERMINING DOSE PER UNIT CUMULATED ACTIVITY FROM EXPOSURE TO PATIENTS ADMINISTERED RADIOACTIVE MATERIAL, The Journal of nuclear medicine, 38(5), 1997, pp. 968-968
Citation: Mg. Stabin et al., RADIATION-DOSIMETRY AND SAFETY CONCERNS FOR A PATIENT RECEIVING THERAPEUTIC ADMINISTRATIONS OF I-131 SODIUM-IODIDE (NAI) WHILE UNDERGOING DIALYSIS, The Journal of nuclear medicine, 37(5), 1996, pp. 1032-1032
Authors:
BALDWIN RM
HORTI AG
BREMNER JD
STRATTON MD
DANNALS RF
RAVERT HT
ZEAPONCE Y
NG CK
DEY HM
SOUFER R
CHARNEY DS
MAZZA SM
SPARKS RB
STUBBS JB
INNIS RB
Citation: Rm. Baldwin et al., SYNTHESIS AND PET IMAGING OF THE BENZODIAZEPINE RECEPTOR TRACER [N-METHYL-C-11]IOMAZENIL, Nuclear medicine and biology, 22(5), 1995, pp. 659-665
Authors:
KLIMAS MT
GOLDSTEIN JM
TRAINOR DA
JACOBS RT
OHNMACHT CJ
ROBERTS RA
YEE YK
TERPKO MO
THOMAS SP
CRONK LA
FRANK CA
HARRIS GD
HULSIZER J
LEWIS JJ
MCLAREN FM
MAUGER RC
MOROSKY GD
RONKIN SM
SIENKEWICZ P
SPARKS RB
ULATOWSKI TG
WILDONGER D
Citation: Mt. Klimas et al., PUTATIVE ATYPICAL ANTIPSYCHOTICS WITH MIXED DOPAMINERGIC (D-1, D-2) AND SEROTONERGIC (5HT(2)) ACTIVITY - THE DESIGN EVOLUTION OF ZD3638, Bioorganic & medicinal chemistry letters, 5(16), 1995, pp. 1795-1800
Citation: Rb. Sparks et al., RADIATION-DOSE ESTIMATES FOR C-11 IOMAZENIL, A BENZODIAZEPINE RECEPTOR RADIOLIGAND, The Journal of nuclear medicine, 35(5), 1994, pp. 160000159-160000159